Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GV0606)
Received: 16 April 2018
Accepted: 16 January 2019
First Online: 25 January 2019
Ethics approval and consent to participate
: The study has been approved by the Ethics Committee of the Faculty of Medicine, University of Freiburg, Germany. All participants provided written informed consent.
: Not applicable.
: AP declares that she served on advisory boards, gave lectures, performed phase 3 studies, or received travel grants within the last 5 years from Eli Lilly and Co, Lundbeck, MEDICE Arzneimittel, Pütter GmbH and Co KG, Novartis, Servier, and Shire; and has authored books and articles on ADHD published by Elsevier, Hogrefe, Schattauer, Kohlhammer, Karger, and Springer.The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.